share_log

Stifel Initiates Coverage On Inari Medical With Hold Rating, Announces Price Target of $50

Benzinga ·  Sep 18 04:46  · Ratings

Stifel analyst Mathew Blackman initiates coverage on Inari Medical (NASDAQ:NARI) with a Hold rating and announces Price Target of $50.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment